BioSpace News Archive

Acne keloidalis is a type of chronic condition due to inflammation of hair follicle. Acne keloidalis usually occurs as an itchy bump at the back of the head or nape of the neck.

The growing demand for endoscopic procedures is likely to play an important role in the growth of the global endoscopic submucosal dissection market over the period of assessment, from 2020 to 2030.

Electrophysiology studies are frequently used in indications of abnormal heart rhythms, to understand the underlying causes and help clinicians decide the most useful treatments.

The demand within the global complement 3 glomerulopathy treatment market is poised to touch new heights in the times to follow.

The allergic rhinitis treatment devices refer to those devices that are utilized for the purpose of treating allergic rhinitis.

Novocure announced that the Swiss Federal Office of Public Health has added Optune in combination with temozolomide to the List of Remedies and Equipment for the treatment of patients with newly diagnosed glioblastoma, effective April 1, 2021.

Polyphor AG announced that the clinical trial independent Data Safety Monitoring Board has completed the third, pre-specified interim analysis, of safety outcomes based on a data cut off of 401 randomized patients in the Phase III pivotal study with balixafortide in HER2 negative, locally recurrent or metastatic breast cancer patients.

The Silicon Review®, a valuable resource bringing business leaders from several industries together, has named Rick Niemi, CEO and founder of Valor Compounding Pharmacy, as one of 30 Best CEOs of the Year 2021.

Relay Therapeutics will receive $75 million upfront and is eligible to receive an additional $25 million in near-term payments and $695 million in additional potential milestones, plus royalties on global net product sales

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces its proprietary hypochlorous acid solution has received U.S. Environmental Protection Agency (EPA) approval for a kill claim against SARS-CoV-2, the virus that causes COVID-19